Literature DB >> 19606270

Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable?

David Kimhy1, Kelly Durbin, Cheryl M Corcoran.   

Abstract

The association between cannabis use and the initial development of psychotic symptoms has attracted increased interest over the past decade. In particular, researchers have attempted to elucidate whether cannabis use increases the risk of psychosis among vulnerable individuals or may just represent attempts to self-medicate distressing symptoms. While a growing literature suggests that cannabis use may contribute to the development of psychotic symptoms, these findings are based primarily on retrospective assessments that have limited ability to clarify the temporal link between cannabis use and psychotic symptoms. The authors review the literature regarding the link between cannabis use and psychotic symptoms; point out the limitations associated with retrospective assessments; and discuss advantages of incorporating daily diary methods, such as Experience Sampling Method (ESM), to study cannabis use and symptoms during daily functioning in "real world" environments. The authors also discuss potential future applications of ESM in research and clinical practice that may inform the identification of individuals vulnerable to develop psychotic symptoms, as well as the development of treatments that target this population.

Entities:  

Year:  2009        PMID: 19606270      PMCID: PMC2709865     

Source DB:  PubMed          Journal:  Prim psychiatry        ISSN: 1082-6319


  38 in total

1.  Cannabis-induced psychosis-like experiences are associated with high schizotypy.

Authors:  E J Barkus; J Stirling; R S Hopkins; S Lewis
Journal:  Psychopathology       Date:  2006-04-12       Impact factor: 1.944

Review 2.  Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.

Authors:  Nasra Haroun; Laura Dunn; Ansar Haroun; Kristin S Cadenhead
Journal:  Schizophr Bull       Date:  2005-10-05       Impact factor: 9.306

3.  Generalized and specific neurocognitive deficits in prodromal schizophrenia.

Authors:  Todd Lencz; Christopher W Smith; Danielle McLaughlin; Andrea Auther; Emilie Nakayama; Lauren Hovey; Barbara A Cornblatt
Journal:  Biol Psychiatry       Date:  2005-12-01       Impact factor: 13.382

4.  Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.

Authors:  H Valerie Curran; Catherine Brignell; Sally Fletcher; Paul Middleton; John Henry
Journal:  Psychopharmacology (Berl)       Date:  2002-07-23       Impact factor: 4.530

5.  Substance use and cognition in early psychosis.

Authors:  Alissa Pencer; Jean Addington
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

6.  Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis.

Authors:  Warrick J Brewer; Shona M Francey; Stephen J Wood; Henry J Jackson; Christos Pantelis; Lisa J Phillips; Alison R Yung; Vicki A Anderson; Patrick D McGorry
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

7.  Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.

Authors:  H Verdoux; C Gindre; F Sorbara; M Tournier; J D Swendsen
Journal:  Psychol Med       Date:  2003-01       Impact factor: 7.723

8.  Use of Palm computer as an adjunct to cognitive-behavioural therapy with an ultra-high-risk patient: a case report.

Authors:  David Kimhy; Cheryl Corcoran
Journal:  Early Interv Psychiatry       Date:  2008-11       Impact factor: 2.732

9.  Motivations that maintain substance use among individuals with psychotic disorders.

Authors:  Catherine Spencer; David Castle; Patricia T Michie
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

Review 10.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

View more
  1 in total

1.  Effects of Δ-THC on Working Memory: Implications for Schizophrenia?

Authors:  Nehal P Vadhan; Mark R Serper; Margaret Haney
Journal:  Prim psychiatry       Date:  2009-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.